Navigation Links
Ovarian transplantation: First baby is born after a new technique
Date:6/29/2009

Amsterdam, The Netherlands: A new technique for transplanting the ovaries of women who have lost their fertility as a result of cancer treatment was outlined to the 25th annual conference of the European Society of Human Reproduction and Embryology today (Monday 29 June). Dr. Pascal Piver, manager of the IVF Centre at Limoges University Hospital, Limoges, France, described a new, two-step method of ovarian transplant that has produced excellent results in women whose ovaries have been frozen because of cancer treatment. He said that his team's technique worked to restore ovarian function quickly and already one patient from his clinic had had a baby and another had become pregnant.

"On June 22, a baby girl was born to a mother who had been menopausal for two years as a result of treatment for sickle cell anaemia. After transplanting her own ovarian tissue she started ovulating in four months and became pregnant naturally six months after transplantation. Both mother and baby are doing well", he said.

Dr. Piver and colleagues set out to tackle one of the biggest problems of ovarian transplantation: the low response to stimulation caused by insufficient vascularisation of the transplanted tissue.

"In order for a woman to become pregnant, the ovaries need to be responsive to the action of hormones that cause them to release eggs each month," he explained. "If the blood supply to the ovaries is insufficient, this will not happen, even though the transplant may look as though it has been successful."

To overcome this problem they carried out a two-stage procedure, first grafting small pieces of the frozen ovarian tissue in the ovarian and peritoneal areas three days before the real transplant. The first graft encourages the growth of blood vessels and paves the way for the ovary to become fully functioning in a shorter time scale than would be possible if all the tissue were to be transplanted at the same time.

The
'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Mutation of the COX2 gene can double or treble a womans risk of ovarian cancer
2. Ovarian cancer stem cells identified, characterized
3. Oocyte-specific gene mutations cause premature ovarian failure
4. TG2 identified as potential therapeutic target in chemo-resistant ovarian cancer
5. Promising new treatment option for women with recurrent ovarian cancer
6. Genetic testing for breast or ovarian cancer risk may be greatly underutilized
7. Ovarian transplantation: New technique gives greatly improved results in this delicate operation
8. Which came first, the moth or the cactus?
9. First all-African GM crop is resistant to maize streak virus
10. Scientists retrace evolution with first atomic structure of an ancient protein
11. CU-Boulder team discovers first ancient manioc fields in Americas

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...t State University assistant professors recently r...on (NSF) to continue research beneficial to unders...90,000. , Christopher Blackwood, assistant profe... awarded grants to support two separate research p... Litter Decomposer Communities and Functions from ...
(Date:11/24/2009)...usands of years it has been prescribed by traditio... from headaches and stomach pain to fever and flu....le University have been able to scientifically pro...a otherwise known as Brazilian mint. , Testing ... led by researcher Graciela Rocha was able to show...
(Date:11/24/2009)...science is opening new doors to understanding how ... hearing of a marine mammal or if they hear it at...X-ray scanners that NASA uses to detect flaws in t...now allowing scientists to peek inside the giant h...hree-dimensional replicas of a whale,s hearing ana...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2Voler Systems Reports 50 25 Growth 14626 1Voler Systems Reports 50 25 Growth 14626 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 1Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 3Santaris Pharma A S Expands Executive Team Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA targeted Drug Develop 5776 1Santaris Pharma A S Expands Executive Team Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA targeted Drug Develop 5776 2Santaris Pharma A S Expands Executive Team Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA targeted Drug Develop 5776 3Santaris Pharma A S Expands Executive Team Appoints Chief Medical Officer and Chief Business Officer to Advance Proprietary RNA targeted Drug Develop 5776 4
...mmonwealth University Massey Cancer Center have id...ible new therapeutic target to improve the efficac...In the Nov. 1 issue of the journal Cancer Research...er cells and established a role of sphingosine kin...id mediator sphingosine-1-phosphate in the death o...
...the world is still plagued by diseases we cannot t...ast complexity of the human immune system. Danish ... help expose a complicated but crucial part of the...an lead to entirely new vaccines and treatments. ... of Health Sciences at the University of Copenhage...
...can contribute as much as vehicles to carbon emiss...hly variable. New research published in the online... quantifies these emissions and suggests fires wil...forts. , Christine Wiedinmyer of the National Cen... University of Colorado, both in Boulder, US, used...
Other Biology News:Potential new therapeutic molecular target to fight cancer 2US faces burning emissions issue 2
(Date:11/25/2009)...chromatodayannouncedtheappointmentofPeterMoldt,PhD...porkastheNovoA/SrepresentativeontheCompany,sBoard....s. ,, "WeareverypleasedtowelcomePeterMoldttothe...dguidanceasCytochromacontinuestomakeprogressinbeco...any,"statedAlanLewis,PhD,ChairmanofCytochroma,sBoa...
(Date:11/25/2009)...ll/--ArdeaBiosciences,Inc.(Nasdaq: RDEA )announced...ecutiveofficer,willpresentatthePiperJaffray21stAnn...easfollows:,PiperJaffray21stAnnualHealthCareConfe...ternTime,Location:TheNewYorkPalaceHotel,NewYork,NY.../,target=,_blank,title=,http://www.corporate-ir.n...
(Date:11/24/2009)...so Visit Detroit , (Vocus...ch Ambassador for International Investment, and Ch..., , ,What: Ambassador Appia is available to meet w...es adopted by France to further develop the financ...and development., , ,When: Available for Interview...
(Date:11/24/2009)...PRNewswire-FirstCall/--DowAgroSciencesCanadaannoun...ionofThompsonsLimitedofBlenheim,Ontario.Theadditio...rentseedsbusinessasthecompanyanticipatestheintrodu...HerbicideTolerantTraitTechnologyincornin2012.Thetr...Thisacquisitionbringstogethertwostrongprogressivec...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
... SBIR Grant Funding to Advance the Development of ... RNAi Drugs, CARLSBAD, Calif., Oct. 3 Isis,Pharm...that it has been,awarded a multi-year Phase 2 Smal... National Institutes of Health (NIH) for up to $1.... exploit the RNA interference (RNAi),antisense mec...
...T LAFAYETTE, Ind. - Engineers have shown how to gr...es onto the surfaces of computer chips to enhance ...ps connect to cooling devices called heat sinks. ,...n to outperform conventional "thermal interface ma... does not require elaborate clean-room environment...
...A, Calif., Oct. 2 MannKind Corporation,(Nasdaq: ...a total of,27,014,686 shares of its common stock i...ts principal stockholder, Chief Executive Officer ... groups of investors,including accounts managed by...d shares, 15,940,489 shares were sold to Mr. Mann ...
Other Biology Technology:Isis Awarded $1.5 Million NIH Grant to Improve Chemical Properties of RNAi-Based Therapeutics 2Isis Awarded $1.5 Million NIH Grant to Improve Chemical Properties of RNAi-Based Therapeutics 3Nanotube forests grown on silicon chips for future computers, electronics 2Nanotube forests grown on silicon chips for future computers, electronics 3MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock 2MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock 3
Eosinophil Chip-IHC from 3H Biomedical AB
B Cell Chip-IHC from 3H Biomedical AB
Basophil Chip-IHC from 3H Biomedical AB
UCB CD4 T Cell Chip-IHC from 3H Biomedical AB
Biology Products: